Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters segment includes Standard Balloon Catheters and PTA Peripheral DCB Catheters. PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters segment includes Standard Balloon Catheters and PTA Peripheral DCB Catheters. PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
1.2 List of Figures
2 Introduction
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Overview
3 Products under Development
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Ongoing Clinical Trials
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Ongoing Clinical Trials
4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Companies and Product Overview
5.1 Andramed GmbH Company Overview
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 AnGes Inc Company Overview
5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioCure, Inc. Company Overview
5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ascenion GmbH Company Overview
5.4.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Boston Scientific Corp Company Overview
5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cardionovum GmbH Company Overview
5.6.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cardiovascular Systems Inc Company Overview
5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Chansu Vascular Technologies LLC Company Overview
5.8.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Concept Medical Inc Company Overview
5.9.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Contego Medical LLC Company Overview
5.10.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Endocor GmbH Company Overview
5.11.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.12 eucatech AG Company Overview
5.12.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
5.13 Genesis MedTech International Pvt Ltd Company Overview
5.13.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Hexacath SA Company Overview
5.14.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.15.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Lutonix Inc Company Overview
5.16.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 M.A. Med Alliance SA Company Overview
5.17.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
5.18 Medtronic Plc Company Overview
5.18.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Micell Technologies Inc Company Overview
5.19.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 NuVascular Technologies Inc Company Overview
5.20.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OrbusNeich Company Overview
5.21.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.22 Orchestra BioMed Inc Company Overview
5.22.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Pulsus Medical LLC (Inactive) Company Overview
5.23.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.24 QT Vascular Ltd Company Overview
5.24.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.25.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.26.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.27 Shockwave Medical Inc Company Overview
5.27.1 Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 SiL Vascular Ltd Company Overview
5.28.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Spectranetics Corp Company Overview
5.29.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.30 Stemplant LLC Company Overview
5.30.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 SurModics Inc Company Overview
5.31.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
5.32.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Tailored Medical Devices Inc Company Overview
5.33.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Transit Scientific LLC Company Overview
5.34.1 Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.35 TransMed7 LLC Company Overview
5.35.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 Vascular Nanotransfer Technologies Company Overview
5.36.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.37 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
5.37.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 AnGes Inc Company Overview
5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioCure, Inc. Company Overview
5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ascenion GmbH Company Overview
5.4.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Boston Scientific Corp Company Overview
5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cardionovum GmbH Company Overview
5.6.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cardiovascular Systems Inc Company Overview
5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Chansu Vascular Technologies LLC Company Overview
5.8.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Concept Medical Inc Company Overview
5.9.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Contego Medical LLC Company Overview
5.10.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Endocor GmbH Company Overview
5.11.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.12 eucatech AG Company Overview
5.12.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
5.13 Genesis MedTech International Pvt Ltd Company Overview
5.13.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Hexacath SA Company Overview
5.14.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.15.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Lutonix Inc Company Overview
5.16.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 M.A. Med Alliance SA Company Overview
5.17.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
5.18 Medtronic Plc Company Overview
5.18.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Micell Technologies Inc Company Overview
5.19.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 NuVascular Technologies Inc Company Overview
5.20.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OrbusNeich Company Overview
5.21.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.22 Orchestra BioMed Inc Company Overview
5.22.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Pulsus Medical LLC (Inactive) Company Overview
5.23.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.24 QT Vascular Ltd Company Overview
5.24.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.25.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.26.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.27 Shockwave Medical Inc Company Overview
5.27.1 Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 SiL Vascular Ltd Company Overview
5.28.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Spectranetics Corp Company Overview
5.29.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.30 Stemplant LLC Company Overview
5.30.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 SurModics Inc Company Overview
5.31.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
5.32.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Tailored Medical Devices Inc Company Overview
5.33.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Transit Scientific LLC Company Overview
5.34.1 Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.35 TransMed7 LLC Company Overview
5.35.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 Vascular Nanotransfer Technologies Company Overview
5.36.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.37 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
5.37.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters- Recent Developments
6.1 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.2 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
6.3 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
6.4 Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
6.7 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.8 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
6.9 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
6.10 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.11 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.12 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.13 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.14 Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
6.15 Apr 29, 2021: Teleflex Reports First Quarter 2021 Results
6.16 Apr 15, 2021: Qt Vascular announces Annual General Meeting
6.17 Mar 26, 2021: Qt Vascular announce Financial Statements
6.18 Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
6.19 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.20 Mar 10, 2021: Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
6.21 Feb 22, 2021: Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D
6.22 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.23 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
6.24 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.25 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.26 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
6.27 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
6.28 Feb 04, 2021: Terumo announce Financial Statements
6.29 Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
6.30 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
6.31 Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
6.32 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
6.33 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience
6.34 Oct 27, 2020: Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
6.35 Oct 21, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
6.2 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
6.3 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
6.4 Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
6.7 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.8 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
6.9 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
6.10 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.11 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.12 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.13 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.14 Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
6.15 Apr 29, 2021: Teleflex Reports First Quarter 2021 Results
6.16 Apr 15, 2021: Qt Vascular announces Annual General Meeting
6.17 Mar 26, 2021: Qt Vascular announce Financial Statements
6.18 Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
6.19 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.20 Mar 10, 2021: Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
6.21 Feb 22, 2021: Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D
6.22 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.23 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
6.24 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.25 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.26 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
6.27 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
6.28 Feb 04, 2021: Terumo announce Financial Statements
6.29 Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
6.30 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
6.31 Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
6.32 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
6.33 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience
6.34 Oct 27, 2020: Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
6.35 Oct 21, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Segment
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Territory
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Regulatory Path
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Estimated Approval Date
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Ongoing Clinical Trials
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Companies - Pipeline Products by Stage of Development
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
- Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Zero-Profile PTA Balloon - Product Status
- Zero-Profile PTA Balloon - Product Description
- AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
- NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
- NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
- AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- AngioCure TOP-C Smart Balloon Catheter - Product Status
- AngioCure TOP-C Smart Balloon Catheter - Product Description
- Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Paclitaxel-Coated Balloon Catheter - Product Status
- Paclitaxel-Coated Balloon Catheter - Product Description
- Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Athletis PTA Balloon Dilatation Catheter - Product Status
- Athletis PTA Balloon Dilatation Catheter - Product Description
- Drug Coated Balloon - Below-The-Knee (BTK) - Product Status
- Drug Coated Balloon - Below-The-Knee (BTK) - Product Description
- High Pressure Balloon - Venous Disease - Product Status
- High Pressure Balloon - Venous Disease - Product Description
- Next Generation 0.018” Balloon - Product Status
- Next Generation 0.018” Balloon - Product Description
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Status
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Description
- Boston Scientific Corp - Ongoing Clinical Trials Overview
- Ranger Paclitaxel-Coated PTA Balloon Catheter - A Prospective, Single-Centre Study Investigating the Clinical Use and Safety of the Jetstream Atherectomy With Drug Coated Balloon (Ranger) for the Treatment of Dysfunctional Arterio-Venous Graft Stenosis
- Ranger Paclitaxel-Coated PTA Balloon Catheter - A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): Real Life Observational Study
- Ranger Paclitaxel-Coated PTA Balloon Catheter - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Prospective, Non-randomized, Multicenter Clinical Study of the Boston Scientific Paclitaxel-coated PTA Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
- Ranger Paclitaxel-Coated PTA Balloon Catheter - Ranger Drug-coated Balloon Catheters Post Market Surveillance
- Ranger Paclitaxel-Coated PTA Balloon Catheter - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
- Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
- LEGFLOW OTW - Product Status
- LEGFLOW OTW - Product Description
- Cardionovum GmbH - Ongoing Clinical Trials Overview
- LEGFLOW OTW - Evaluation of the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter (LEGFLOW) in Treatment of Stenosis or Occlusion in Femoral-popliteal Arteries: A Prospective, Multicenter, Randomized, Controlled Clinical Study
- LEGFLOW OTW - Evaluation the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter (LEGFLOW) in Treatment of Stenosis or Occlusion in below the Knee Arteries: A Prospective, Multicenter, Randomized, Controlled Clinical Study
- Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- Peripheral PTA Balloon Catheter - Product Status
- Peripheral PTA Balloon Catheter - Product Description
- Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- Peripheral Everolimus Drug-Coated Balloon - Product Status
- Peripheral Everolimus Drug-Coated Balloon - Product Description
- Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- MagicTouch PTA Balloon Catheter - Product Status
- MagicTouch PTA Balloon Catheter - Product Description
- Concept Medical Inc - Ongoing Clinical Trials Overview
- MagicTouch PTA Balloon Catheter - Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA) - Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease: XTOSI Pilot Study
- MagicTouch PTA Balloon Catheter - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
- MagicTouch PTA Balloon Catheter - Head-to-Head Comparison of Sirolimus Versus Paclitaxel Drug-Eluting Balloon Angioplasty in the Femoropopliteal Artery
- MagicTouch PTA Balloon Catheter - Major Adverse Limb Events in Patients with Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated with Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
- MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First SirolimUs Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease: FUTURE BTK
- MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Superficial Femoral Artery and Popliteal Artery Disease
- Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- Superficial Femoral Artery Balloon - Product Status
- Superficial Femoral Artery Balloon - Product Description
- Tibial Artery Drug Eluting Balloon - Product Status
- Tibial Artery Drug Eluting Balloon - Product Description
- Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Endorenal - Product Status
- Endorenal - Product Description
- eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
- Support - Product Status
- Support - Product Description
- Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Chocolate Touch - Product Status
- Chocolate Touch - Product Description
- Genesis MedTech International Pvt Ltd - Ongoing Clinical Trials Overview
- Chocolate Touch - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
- Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview
- MERAK PTA Dilatation Catheter - Product Status
- MERAK PTA Dilatation Catheter - Product Description
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
- Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
- Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
- Lutonix 014 Drug Coated Balloon PTA Catheter - Product Status
- Lutonix 014 Drug Coated Balloon PTA Catheter - Product Description
- Lutonix Inc - Ongoing Clinical Trials Overview
- Lutonix 014 Drug Coated Balloon PTA Catheter - A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-knee (BTK) Arteries: Lutonix BTK Trial
- M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
- SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Status
- SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Description
- M.A. Med Alliance SA - Ongoing Clinical Trials Overview
- SELUTION SLR 018 DEB - Peripheral Artery Disease - A Prospective Multi-center Study to Assess the Safety and Efficacy of SELUTION SLR for the Treatment of Lesions of Superficial Femoral Arteries and/or Popliteal Arteries
- SELUTION SLR 018 DEB - Peripheral Artery Disease - Intervention with Selution SLR Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
- SELUTION SLR 018 DEB - Peripheral Artery Disease - Prospective Registry to Investigate the Safety and Efficacy of the Treatment with the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-inguinal Disease in Patients with Chronic Limb Threatening Ischemia from Singapore
- SELUTION SLR 018 DEB - Peripheral Artery Disease - SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
- SELUTION SLR 018 DEB - Peripheral Artery Disease - SELUTION SLR 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis
- SELUTION SLR 018 DEB - Peripheral Artery Disease - SUCCESS (Selution, Safety, Efficacy, Health Economics and Proms) PTA Study
- Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- IN.PACT Admiral DEB - BTK - Product Status
- IN.PACT Admiral DEB - BTK - Product Description
- Medtronic Plc - Ongoing Clinical Trials Overview
- IN.PACT Admiral DEB - BTK - Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries
- Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Drug-Coated Balloon - Product Status
- Drug-Coated Balloon - Product Description
- NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- NuSpun DE Balloon - Product Status
- NuSpun DE Balloon - Product Description
- OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
- Limus Drug Coated Balloon - Peripheral - Product Status
- Limus Drug Coated Balloon - Peripheral - Product Description
- Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- Virtue Sirolimus-Eluting Balloon - BTK - Product Status
- Virtue Sirolimus-Eluting Balloon - BTK - Product Description
- Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Micro-Perforated Catheter Balloon Drug Delivery System - Product Status
- Micro-Perforated Catheter Balloon Drug Delivery System - Product Description
- QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Silk PTA Balloon Catheter - Product Status
- Silk PTA Balloon Catheter - Product Description
- QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Kinesyx-Based Peripheral Drug Coated Balloon - Product Status
- Kinesyx-Based Peripheral Drug Coated Balloon - Product Description
- Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- PTA Balloon Catheter - Product Status
- PTA Balloon Catheter - Product Description
- Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- LX - Product Status
- LX - Product Description
- M5+ Peripheral Intravascular Lithotripsy (IVL) System - Product Status
- M5+ Peripheral Intravascular Lithotripsy (IVL) System - Product Description
- S4+ - Product Status
- S4+ - Product Description
- Shockwave Medical Inc - Ongoing Clinical Trials Overview
- M5+ Peripheral Intravascular Lithotripsy (IVL) System - Prospective, Multi-center, Single-arm Study of the Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL) System in Calcified Peripheral Arteries
- SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Peripheral Vascular Balloon - Product Status
- Peripheral Vascular Balloon - Product Description
- Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
- Stellarex 0.014 Over-The-Wire Drug-Coated Angioplasty Balloon - Product Status
- Stellarex 0.014 Over-The-Wire Drug-Coated Angioplasty Balloon - Product Description
- Spectranetics Corp - Ongoing Clinical Trials Overview
- Stellarex 0.014 Over-The-Wire Drug-Coated Angioplasty Balloon - Prospective, Multi-center Study to Evaluate Treatment of Subjects with Occlusive Disease with a Novel Paclitazel-coated Angioplasty Balloon in Below-the-knee (BTK) Arteries: A Post Market Clinical Study
- Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
- Peripheral Vascular Angioplasty Delivery Device - Product Status
- Peripheral Vascular Angioplasty Delivery Device - Product Description
- SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
0.018” Radial PTA Balloon Catheter - Product Description
0.035” Next Generation Workhorse PTA Catheter - Product Status
0.035” Next Generation Workhorse PTA Catheter - Product Description
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter - Product Status
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter - Product Description
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter - Product Status
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter - Product Description
- Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Status
- Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Description
- Sundance BTK DCB - Product Status
- Sundance BTK DCB - Product Description
- SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Status
- SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Description
- SurModics Inc - Ongoing Clinical Trials Overview
- SurVeil Drug Coated Balloon - Peripheral Artery Disease - A Prospective, Multi-center, Single-arm Study to Assess the Safety and Performance of the Surmodics Drug Coated Balloon in the Treatment of Subjects with Obstructive Lesions of Arteriovenous Fistulae for Hemodialysis, Including Native or Synthetic Grafts
- SurVeil Drug Coated Balloon - Peripheral Artery Disease - The Randomized and Controlled Noninferiority Trial to Evaluate Safety and Clinical Efficacy of the SurVeil Drug-coated Balloon in the Treatment of Subjects with Stenotic Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
- Sundance BTK DCB - A Prospective, Multi-center, Single-arm, Feasibility Study to Assess the Safety and Performance with the SUNDANCE DruG Coated Balloon for the Treatment of De Novo or Restenotic Lesions in Infra-popliteal Arteries
- Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- High Pressure Balloon - Product Status
- High Pressure Balloon - Product Description
- Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
- MR-PEO-DCB - Product Status
- MR-PEO-DCB - Product Description
- Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
- XO Score - 3F - Product Status
- XO Score - 3F - Product Description
- XO Score - 4F - Product Status
- XO Score - 4F - Product Description
- XO Score - 5F - Product Status
- XO Score - 5F - Product Description
- TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
- Zeppelin II - Product Status
- Zeppelin II - Product Description
- Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
- Mitomycin-Based Drug Coated Balloon - Peripheral - Product Status
- Mitomycin-Based Drug Coated Balloon - Peripheral - Product Description
- Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Status
- Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Description
- Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- PTA Scoring Balloon Catheter - Product Status
- PTA Scoring Balloon Catheter - Product Description
- Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Status
- Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Description
- Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Status
- Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Description
- Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Status
- Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Description
- Venous PTA Balloon Catheter - Product Status
- Venous PTA Balloon Catheter - Product Description
- ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - Product Status
- ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - Product Description
- Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
- ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - The Efficacy and Safety Study for Endovascular Treatment of Symptomatic Intracranial Atherosclerosis Using Drug-eluting Balloon Dilatation Catheter: An Prospective Multicenter Single-arm Trial
- Ultrafree Drug Coated PTA Balloon Catheter - BTK - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for the Treatment of Stenosis or Occlusion in Below-the-knee
- Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Dialysis Access
- Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Vertebral Artery Stenosis
- Glossary
List of Figures
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Segment
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Territory
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Regulatory Path
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Estimated Approval Date
- Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Andramed GmbH
- AnGes Inc
- AngioCure, Inc.
- Ascenion GmbH
- Boston Scientific Corp
- Cardionovum GmbH
- Cardiovascular Systems Inc
- Chansu Vascular Technologies LLC
- Concept Medical Inc
- Contego Medical LLC
- Endocor GmbH
- eucatech AG
- Genesis MedTech International Pvt Ltd
- Hexacath SA
- Lifetech Scientific (Shenzhen) Co Ltd
- Lutonix Inc
- M.A. Med Alliance SA
- Medtronic Plc
- Micell Technologies Inc
- NuVascular Technologies Inc
- OrbusNeich
- Orchestra BioMed Inc
- Pulsus Medical LLC (Inactive)
- QT Vascular Ltd
- QualiMed Innovative Medizinprodukte GmbH
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Shockwave Medical Inc
- SiL Vascular Ltd
- Spectranetics Corp
- Stemplant LLC
- SurModics Inc
- Suzhou Tianhong Shengjie Medical Co Ltd
- Tailored Medical Devices Inc
- Transit Scientific LLC
- TransMed7 LLC
- Vascular Nanotransfer Technologies
- Zylox-Tonbridge Medical Technology Co Ltd